Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Erythropoiesis01:14

Erythropoiesis

5.7K
Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
5.7K
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

3.6K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
3.6K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

2.7K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Last Mile in CAR-T Cell Therapy.

Transplantation and cellular therapy·2026
Same author

Acquired Cutis Laxa Secondary to Hematological Malignancy: A Report of Two Cases.

Indian dermatology online journal·2026
Same author

HuR enhances SARS-CoV-2 non-structural protein translation through the genomic 5'-UTR, by promoting polypyrimidine tract-binding protein binding.

Journal of virology·2026
Same author

Fecal Calprotectin as a biomarker for early diagnosis and prediction of steroid response in Acute Gastrointestinal Graft versus Host Disease.

Blood cell therapy·2026
Same author

International Survey for Antiemetics in Hematopoietic Stem Cell Transplantation in the APBMT Centers.

Blood cell therapy·2026
Same author

Clinical Outcomes of Allogeneic Stem Cell Transplantation in Myelofibrosis - A Single Center Experience.

Blood cell therapy·2026

Related Experiment Video

Updated: May 3, 2026

Electrophoretic Mobility Shift Assay EMSA for the Study of RNA-Protein Interactions: The IRE/IRP Example
12:44

Electrophoretic Mobility Shift Assay EMSA for the Study of RNA-Protein Interactions: The IRE/IRP Example

Published on: December 3, 2014

54.0K

Erythroid activity modulates iron regulation in pathological erythropoiesis: A cross-sectional case-control study.

Sreenithi Santhakumar1,2, Leo Stephen1, Arun Jose Nellickal3

  • 1Department of Haematology, Christian Medical College, Vellore, Tamil Nadu, India.

The Indian Journal of Medical Research
|August 29, 2025
PubMed
Summary

Iron regulation is altered in both beta-thalassemia and polycythemia vera due to increased erythropoiesis. These blood disorders impact iron transport and systemic iron levels differently.

Keywords:
Beta thalassemiairon regulatorspolycythaemia vera

More Related Videos

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
05:08

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Published on: January 31, 2022

4.8K
Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes
08:53

Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes

Published on: January 10, 2025

586

Related Experiment Videos

Last Updated: May 3, 2026

Electrophoretic Mobility Shift Assay EMSA for the Study of RNA-Protein Interactions: The IRE/IRP Example
12:44

Electrophoretic Mobility Shift Assay EMSA for the Study of RNA-Protein Interactions: The IRE/IRP Example

Published on: December 3, 2014

54.0K
Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
05:08

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Published on: January 31, 2022

4.8K
Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes
08:53

Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes

Published on: January 10, 2025

586

Area of Science:

  • Hematology
  • Molecular Biology
  • Genetics

Background:

  • Beta-thalassemia and polycythemia vera (PV) involve genetic defects or altered red blood cell (RBC) synthesis.
  • Both conditions exhibit stress erythropoiesis, leading to accelerated erythroid expansion.
  • Iron regulation in these diseases remains incompletely understood.

Purpose of the Study:

  • To analyze iron parameters and iron regulatory gene expression in patients with beta-thalassemia and PV.
  • To compare these parameters with healthy controls.

Main Methods:

  • Biochemical analysis of iron parameters.
  • Gene expression analysis of iron regulatory genes.
  • Study included patients with transfusion-dependent thalassemia (TDT), non-transfusion-dependent thalassemia (NTDT), PV, and healthy controls.

Main Results:

  • Elevated soluble transferrin receptor (sTfR) in both diseases indicates increased erythropoietic activity.
  • Serum ferritin levels were significantly higher in beta-thalassemia major compared to NTDT, but subnormal in PV.
  • Hepcidin levels were low relative to ferritin in TDT, and reduced in PV due to increased erythropoiesis.
  • Diminished TFRC expression in thalassemia reticulocytes suggested impaired iron uptake, while PV showed increased TFRC and FPN1B expression.

Conclusions:

  • Increased erythropoietic activity critically influences iron transport to the bone marrow.
  • Iron regulation within erythroid cells is modulated, affecting systemic iron levels.
  • Distinct iron dysregulation patterns exist between beta-thalassemia and PV.